Safer mRNA Vaccines: Phenol Lipids Reduce Risks
Old Chemistry, New Frontiers: Revolutionizing mRNA Delivery with Novel Lipids
Table of Contents
A groundbreaking discovery in lipid chemistry is poised to enhance the effectiveness and reduce the side effects of mRNA-based therapies, from cancer treatments to vaccines.
Researchers have developed a new class of lipids, dubbed C-a16, that considerably improve the delivery of genetic material into cells. This innovation, rooted in a century-old chemical reaction, promises to unlock new frontiers in medicine, offering the potential for safer, stronger, and more targeted treatments.
Enhancing mRNA Delivery: A brighter Glow, A Stronger Fix
To assess the efficacy of the new C-a16 lipids, scientists employed them in a classic experiment: delivering the gene responsible for firefly luminescence into cells. The results were striking. In animal models, the glow produced by cells treated with C-a16 lipids was approximately 15 times brighter compared to those treated with lipid nanoparticles (LNPs) used in Onpattro, an FDA-approved medication for hereditary transthyretin amyloidosis (hATTR).
Beyond simply enhancing gene expression, the C-a16 lipids also proved adept at facilitating gene editing. When used with CRISPR technology to correct the faulty gene causing hATTR, these novel lipids more than doubled the treatment’s effectiveness in a mouse model when compared to existing delivery methods. This suggests a notable leap forward in the precision and power of gene therapy.
Striking Results in Cancer and COVID-19 Treatments
The impact of C-a16 lipids extends to critical areas like cancer therapy and vaccine development. In preclinical studies involving a melanoma model, mRNA cancer treatments delivered via C-a16 lipids led to tumor shrinkage that was three times more effective than treatments using the LNPs found in current COVID-19 vaccines. Moreover, these new lipids appear to bolster the immune system’s response. They provided a significant boost to cancer-fighting T cells,enhancing their ability to identify and eliminate tumor cells with reduced oxidative stress.
The potential for C-a16 lipids in vaccine development is equally promising. When used to formulate COVID-19 mRNA vaccines, the immune response observed in animal models was five times stronger than that elicited by standard vaccine formulations.
“By causing less disruption to cellular machinery, the new, phenol-containing lipids can enhance a wide range of LNP applications,” explained lead researcher Dr. Kim.
old Chemistry, New Frontiers
The discovery highlights the power of revisiting fundamental chemical processes. The researchers utilized the Mannich reaction, a chemical process discovered over a century ago, to create these advanced lipids.This success opens the door to exploring other “overlooked” chemical reactions that could lead to new LNP-enhancing formulations.
“We tried applying one reaction discovered a century ago, and found it could drastically improve cutting-edge medical treatments,” said Dr. Mitchell. “It’s exciting to imagine what else remains to be rediscovered.”
This innovative approach not only promises to reduce potential side effects in mRNA vaccines but also paves the way for a new generation of more potent and safer therapies across various medical disciplines.
Reference: Gong N, Kim D, Alameh MG, et al. Mannich reaction-based combinatorial libraries identify antioxidant ionizable lipids for mRNA delivery with reduced immunogenicity.Nat Biomed Eng. 2025. doi: 10.1038/s41551-025-01422-8
This article has been republished from the following materials. Note: material may have been edited for length and content. for further data, please contact the cited source.Our press release publishing policy can be accessed hear.